DETQ is an experimental drug which acts as a positive allosteric modulator of the dopamine D1 receptor. It increases the D1 receptor-mediated response to endogenous dopamine levels, and was developed as a potential treatment for Parkinson's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.